Φορτώνει......
Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
BACKGROUND: Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed ‘ultra-central’ tumors. As there is no consensus regarding the opt...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Radiat Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880025/ https://ncbi.nlm.nih.gov/pubmed/29606150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-018-1001-6 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|